These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8447845)

  • 21. Stereoselective pharmacokinetics of diniconazole enantiomers in rabbits.
    Wang Q; Qiu J; Zhou Z; Cao A; Wang X; Zhu W; Dang Z
    Chirality; 2009 Jul; 21(7):699-703. PubMed ID: 18973222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients.
    Alshowaier IA; el-Yazigi A; Ezzat A; Abd el-Warith A; Nicholls PJ
    J Clin Pharmacol; 1999 Nov; 39(11):1136-42. PubMed ID: 10579143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects.
    Gustavson LE; Schweitzer SM; Burt DA; Achari R; Rieser MJ; Edeki T; Chira T; Yannicelli HD; Kelly MT
    Clin Ther; 2006 Mar; 28(3):373-87. PubMed ID: 16750452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis.
    Glówka FK; Strzelecka D; Zapalski S
    Chirality; 2001 Jun; 13(6):308-12. PubMed ID: 11370020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs.
    Trejtnar F; Král R; Pávek P; Wsól V
    Chirality; 2003 Oct; 15(8):724-9. PubMed ID: 12923810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat.
    Jamali F; Lovlin R; Corrigan BW; Davies NM; Aberg G
    Chirality; 1999; 11(3):201-5. PubMed ID: 10079499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man.
    Główka FK
    Chirality; 2000 Jan; 12(1):38-42. PubMed ID: 10602265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of thiamylal enantiomers in humans.
    Sueyasu M; Ikeda T; Taniyama T; Futugami K; Kataoka Y; Oishi R
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):128-32. PubMed ID: 9089003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogs.
    Wuis EW; Dirks MJ; Termond EF; Vree TB; Van der Kleijn E
    Int J Clin Pharmacol Res; 1989; 9(4):239-46. PubMed ID: 2777427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition in humans of racemic picenadol, an opioid analgesic.
    Franz PM; Anliker SL; Callaghan JT; DeSante KA; Dhahir PH; Nelson RL; Rubin A
    Drug Metab Dispos; 1990; 18(6):968-73. PubMed ID: 1981546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies with beclobrate, a new hypolipidemic agent.
    Adrian RW; Ismail S; Jahn U
    Arzneimittelforschung; 1983; 33(10):1464-8. PubMed ID: 6686044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolism of beclobrate in rat and man].
    Roth VW; Prox A; Ifflaender U
    Arzneimittelforschung; 1985; 35(1A):244-51. PubMed ID: 4039165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers.
    Weber-Grandke H; Hahn G; Mutschler E; Möhrke W; Langguth P; Spahn-Langguth H
    Br J Clin Pharmacol; 1993 Oct; 36(4):363-5. PubMed ID: 12959316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Biopharm Drug Dispos; 1990; 11(6):507-18. PubMed ID: 2207301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers.
    Vezekenyi Z; Ferenci J; Radnai B; Horvath T; Past T; Nagy L; Jávor T
    Int J Clin Pharmacol Res; 1983; 3(2):77-88. PubMed ID: 6679516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance.
    Churchill GC; Strupp M; Galione A; Platt FM
    PLoS One; 2020; 15(2):e0229585. PubMed ID: 32108176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pharmacokinetics of antilipemic agents. 8. Unequivocal characterization of ciprofibrate-O-beta-d-glucuronide].
    Oelschläger H; Kohl C; Armstrong DW; Rothley D
    Arch Pharm (Weinheim); 1991 Aug; 324(8):505-8. PubMed ID: 1781732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.